CLL Society News Archives

April 22, 2022

Patty Koffman Retirement Announcement

After nine years of dedicated service to CLL Society, Patty Koffman, co-founder and communications director for CLL Society, will officially retire from her full-time position with CLL Society on April 30. Patty announced this decision to the Board of Directors in May 2021, allowing us ample time to prepare

March 10, 2022

Dr. Koffman Quoted in LA Times: This Treatment Can Protect Vulnerable People From COVID-19. But Many Don’t Know About It

Our own Dr. Koffman is quoted in his local paper, the LA Times, in this article: This Treatment Can Protect Vulnerable People From COVID. But Many Don’t Know About It.

February 28, 2022

FDA Authorizes Revisions to Evusheld Dosing

Our own Dr. Koffman was quoted by CNN on the impact of the FDA’s decision to double the recommended dose of Evusheld to protect the immunocompromised including those with CLL/SLL against all the COVID-19 variants.

February 28, 2022

PREVENT Pandemics Act Draft–Immunocompromised Collaborative

CLL Society has signed on to the efforts led by the Immune Deficiency Foundation to advocate on behalf of the entire immunocompromised community to “Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics.”

February 21, 2022

Health Professional Radio: Dr. Koffman Discusses Our Vulnerability and Possible Solutions

CLL Society’s own Chief Medical Officer, Dr. Brian Koffman, returns to the radio to beat the drum about those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and others who are immunocompromised (IC) remain at increased risk for severe outcomes with COVID-19.

February 14, 2022

Tribute to Tom Henry

We lost a CLL friend, advocate, and scholar to COVID-19. I am heartbroken and not sure where to start my personal tribute. Tom Henry was a special person, active in multiple forums, extraordinarily generous in sharing his wisdom as a pharmacist, faith, and hard-earned experience as a CLL patient.

January 3, 2022

JAMA: Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Pre-Exposure Prophylaxis

We now have lifesaving therapies for CLL/SLL patients who contract COVID-19, but they are severe shortages leaving many difficult unanswered questions for our community.

November 29, 2021

Patient Advice – Paying it Forward

CLL Society asked CLL/SLL patients what advice they have from their own personal journey that they would like to share with people recently diagnosed with CLL. We received great advice and we are sharing it with you! Please check out this page each week as we release short videos

November 12, 2021

Dr. Koffman’s Radio Interview on the Impact of COVID-19 on the Immunocompromised, Including CLL/SLL Patients

Health Professional Radio (HPR) interviewed Dr. Brian Koffman on this critical subject that is so near and dear to his heart and that of anyone dealing with CLL.

CLL Society News

Patty Koffman Retirement Announcement

Dr. Koffman Quoted in LA Times: This Treatment Can Protect Vulnerable People From COVID-19. But Many Don’t Know About It

FDA Authorizes Revisions to Evusheld Dosing

PREVENT Pandemics Act Draft–Immunocompromised Collaborative

Health Professional Radio: Dr. Koffman Discusses Our Vulnerability and Possible Solutions

Tribute to Tom Henry

JAMA: Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Pre-Exposure Prophylaxis

Patient Advice – Paying it Forward

Dr. Koffman’s Radio Interview on the Impact of COVID-19 on the Immunocompromised, Including CLL/SLL Patients

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT